Emerging Company and Venture Capital

Helping clients launch their businesses and transform their innovative ideas into successful companies.

Key Contacts

Meet Our Team

Areas of Focus

Expand All Collapse All

WilmerHale Launch

A resource for entrepreneurs and founders of startups in various stages of growth, WilmerHale Launch is your source for answers to the questions that impact you every day. We provide the tools and information you need to build your knowledge and position your startup for success.

2024 IPO, Venture Capital and M&A Reports



    • Atom Computing, a developer of quantum computers, in its $60 million Series B financing round.
    • BandLab, a social music platform designed to create and share content with musicians and fans, in its $53 million Series B financing round.
    • Dedrone, an automated drone security platform, in its $60.5 million  Series C financing round.
    • DriveWealth, a pioneer in fractional trading and embedded finance, in its $450 million Series D funding round.
    • Fervo Energy, a provider of clean energy technology, in its $138 million Series C financing round.
    • Flare Therapeutics, a developer of medicines designed for precision oncology, in its $123 million Series B financing round.
    • GentiBio, a biotherapeutics company developing engineered regulatory T cell therapies, in its $157 million Series A financing round.
    • GiveCampus, a social fundraising platform designed to help non-profit educational institutions, in its $50 million Series A financing round.
    • Infinium, an alternate energy producer with the goal of decarbonizing the transportation sector, in its $69 million Series B financing round.
    • Immuta, an AI data management software developer, in a $90 million late stage financing round.
    • Introhive, one of the fastest-growing AI-powered sales and revenue acceleration platforms, in its $100 million Series C financing round.
    • Orna Therapeutics, a biotechnology company pioneering engineered circular therapies, in its $221 million Series B financing round.
    • Rectify Therapeutics, a company developing therapies to treat genetic disorders, in its $100 million Series A financing round.
    • Righthand Robotics, a developer of supply chain logistics equipment, in its $66 million Series C financing round.
    • Tenderly, an Ethereum Blockchain startup, in its $40 million Series B funding round.
    • Verdox, a developer of sustainable technologies focused on reversing climate change, in its $80 million Series A financing round.
    • Volastra Therapeutics, a clinical stage cancer biotechnology company focused on exploiting chromosomal instability (CIN), in its $60 million Series A financing round.
    • Workit Health, a digital healthcare company that provides online and in-person care, in its $118 million Series C financing round.
    • Workrise, a workforce management solution for the industrial trades, in a $300 million Series D financing round.
    • Represented investors such as Bessemer Venture Partners, Casdin Capital, General Catalyst, Khosla Ventures, Pear Ventures, RA Capital, Samsara BioCapital, Spark Capital, and Wellington Management, among numerous others, in venture financings.


  • Award Text

    Recognized as a Top Firm in the Nation for Startups & Emerging Companies

    Chambers USA


  • Award Text

    Recommended for Venture Capital and Emerging Companies

    The Legal 500 United States


  • Award Text

    Named a Leading Law Firm for Venture Capital Law

    U.S. News - Best Lawyers®


  • Chambers USA Guide – Again named our corporate practice among the best in 2024, with sources saying that WilmerHale's corporate team is “proactive in its thinking” and are “very strategic thinkers.” The current edition of Chambers USA also ranked WilmerHale in the following related regions and practices: nationwide for Startups & Emerging Companies; California for Venture Capital; Massachusetts for Corporate/M&A, Private Equity: Venture Capital Investment, and Technology; and Washington DC for Corporate/M&A & Private Equity. WilmerHale was also ranked among the top FinTech law firms in the US in its 2021 FinTech guide.
  • The Legal 500 United States – Recognized WilmerHale among top law firms for our work in the area of Venture Capital and Emerging Companies in its 2010–2024 editions.
  • U.S. News - Best Lawyers® – Recognized in the 2010–2024 “Best Law Firms” rankings. In the 2024 rankings, our corporate, mergers and acquisitions, and venture capital law practices were ranked in the first tier nationally and in Boston, and our corporate law practice was also ranked in the first tier in Colorado, New York and Washington DC.  A source describes our venture capital practice as “impeccable and indispensable. They answer the questions, identify the guardrails, and draw on their experience to help us anticipate strategic opportunities. Their superb legal guidance has allowed us to focus on business growth.”
  • Best Lawyers in America – Recognized 129 WilmerHale partners for 2021, naming eight as “Lawyers of the Year.”
  • Corporate Board Member – In 2014, 2016 and 2018, the most recent edition, WilmerHale was named to Top National Corporate Law Firms list, a comprehensive ranking of the top 25 firms in the nation. Results are based on law firm surveys and feedback from thousands of directors and general counsel.
  • Law360 – Named WilmerHale a Technology Practice Group of the Year in 2016-2018 and 2022, an award recognizing the firm’s key role in the significant matters that made headlines and changed the legal landscape, for three consecutive years. 
  • LMG Life Sciences – Named WilmerHale the US Life Cycle Firm of the Year in 2017–2023 and among the shortlist from 2012–2023. LMG has also ranked the firm in its 2012–2023 editions in corporate, licensing and collaboration, M&A, venture capital and several other practice areas, and named 21 WilmerHale lawyers as “life sciences stars.”
  • Super Lawyers – Our corporate lawyers are consistently recognized as “Super Lawyers” and “Rising Stars” in multiple jurisdictions.

Insights & News


Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.